The advanced therapy sector has experienced exponential growth in recent years related to the number of technologies and vendors entering the medical data devices market. A need for more specific, higher capability devices across multiple geographies has emerged for many clinical trials operations, owing in part to the increased uniqueness of the drugs and therapies undergoing development. In this white paper written by IQVIA Connected Devices leader Mike Bruhns, learn why it is important to not only find the device that meets the needs of your clinical trial, but also how to ask the right questions when choosing the appropriate device, and how to manage the complex logistical and regulatory challenges.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
